Application of risk priority number of failure mode and effects analysis to drug-variant pairs for severe cutaneous adverse reactions in Korean and American populations.
- DOI
- 10.1097/fpc.0000000000000596
- Published
- 2026 Jul 1
- Container
- Pharmacogenetics and genomics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/fpc.0000000000000596,
title = {Application of risk priority number of failure mode and effects analysis to drug-variant pairs for severe cutaneous adverse reactions in Korean and American populations.},
author = {Lee HK and Kang MJ and Kim H and Jang HY and Han N and Kim IW and Oh JM},
year = {2026},
journal = {Pharmacogenetics and genomics},
doi = {10.1097/fpc.0000000000000596},
url = {https://doi.org/10.1097/fpc.0000000000000596}
}RIS
TY - JOUR TI - Application of risk priority number of failure mode and effects analysis to drug-variant pairs for severe cutaneous adverse reactions in Korean and American populations. AU - Lee HK AU - Kang MJ AU - Kim H AU - Jang HY AU - Han N AU - Kim IW AU - Oh JM PY - 2026 JO - Pharmacogenetics and genomics DO - 10.1097/fpc.0000000000000596 UR - https://doi.org/10.1097/fpc.0000000000000596 ER -
APA
HK, L., MJ, K., H, K., HY, J., N, H., IW, K., & JM, O. (2026). Application of risk priority number of failure mode and effects analysis to drug-variant pairs for severe cutaneous adverse reactions in Korean and American populations.. Pharmacogenetics and genomics. https://doi.org/10.1097/fpc.0000000000000596
Source records
- pubmed · retrieved 2026-09-26T11:00:07.013Z